H1B Salary Data

Home › Employers › Sample Healthcare, Inc.

Sample Healthcare, Inc.: H-1B salaries and sponsorship

Sample Healthcare, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $134,000.

Applications (LCAs)3
Certified3
Employer addressSan Francisco, CA
Median offered salary$134,000
Middle half of salaries$133,500–$142,000
10th–90th percentile$133,200–$146,800

Does Sample Healthcare, Inc. sponsor H-1B visas?

Sample Healthcare, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Jul 3, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Strategy Lead1$150,000
Software Engineer1$133,000
Forward Deployed Engineer1$134,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20252$142,000
FY20261$133,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Forward Deployed Engineer$134,000–$180,000
H-1B1 (Singapore) · Level II
San Francisco, CAJul 3, 2025Aug 4, 2025Certified
Strategy Lead$150,000
H-1B1 (Singapore) · Level III
San Francisco, CAFeb 21, 2025Mar 24, 2025Certified
Software Engineer$133,000
H-1B1 (Singapore) · Level I
San Francisco, CAFeb 14, 2025Mar 10, 2025Certified, then withdrawn

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).